Overview
- The loss was disclosed in the federal government’s 2025 public accounts covering the 2024–25 fiscal year.
- PHAC says a single December 2024 incident involving temperature fluctuations in freezer units led to the loss of one volume of a therapeutic drug.
- Health Canada also recorded a separate loss of roughly $1.2 million due to damaged lab equipment.
- Officials say they cannot reveal specific products or quantities for national security reasons and assert the stockpile’s response capacity remains intact, with quality controls and corrective actions in place.
- Conservative health critic Dan Mazier is urging a House of Commons investigation, and the health minister’s office says it is working with PHAC to prevent a recurrence.